ESHRE updated the evidence-based guideline on recurrent pregnancy loss

The updated guideline is now available. The guideline development group hope to ensure this guideline remains relevant and useful to clinical practice, with this updated edition reflecting the latest published studies in the field.

We believe this update will provide even more value to members who rely on the 2017 version for the care and management of women with recurrent pregnancy loss.

In memoriam Joep Geraedts

Professor Joep Geraedts (1948), a long-standing member and past Chair (2007-2009) of ESHRE passed away on 25 December 2022.

Read the In Memoriam by Karen Sermon.

Registration for ESHRE 2023 is now open

We are hopeful that you can all join us for our Annual Meeting to celebrate the world’s largest in-person event in reproductive science and medicine. This 39th annual meeting will be planned primarily as a traditional in-person meeting with the support of live-streamed broadcast presentations from the scheduled live scientific sessions. On-demand access to all presentations will be available to all registrants.

The 5th edition of the Guide to the quality and safety of tissues and cells for human application has been published

The European Directorate for the Quality of Medicines and HealthCare (EDQM) of the Council of Europe released their 5th edition of the Guide to the quality and safety of tissues and cells for human application in December 2022.
The Guide contains technical information and guidance for professionals working in tissue establishments, inspectors auditing these establishments, and Health Authorities responsible for tissues and cells for human application. It collates the most up-to-date information to provide a comprehensive overview of the most recent advances in the field, with the aim to support professionals at a practical level and contribute to improving the rate of successful and safe clinical application of tissues and cells of human origin.